Mid-Del Therapeutic Center, Inc. v. Commissioner

30 F. App'x 889
CourtCourt of Appeals for the Tenth Circuit
DecidedFebruary 20, 2002
Docket01-9000
StatusUnpublished
Cited by5 cases

This text of 30 F. App'x 889 (Mid-Del Therapeutic Center, Inc. v. Commissioner) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mid-Del Therapeutic Center, Inc. v. Commissioner, 30 F. App'x 889 (10th Cir. 2002).

Opinion

ORDER AND JUDGMENT *

PORFILIO, Circuit Judge.

After examining the briefs and appellate record, this panel has determined unanimously to grant the parties’ request for a decision on the briefs without oral argument. See Fed. RApp. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore ordered submitted without oral argument.

Petitioners Mid-Del Therapeutic Center, Inc. (Mid-Del) and D. Richard Ishmael, M.D., PC (PC), appeal the Tax Court’s denial of litigation costs after successfully contesting the Commissioner of the Internal Revenue Service’s (Commissioner) deficiency determinations in docket numbers 9060-97 and 9270-97. Because we conclude the Tax Court did not abuse its discretion in determining that the position *891 of the government at trial was substantially justified, we affirm.

I.

The facts surrounding this dispute are well known to the parties and described at length in both the Tax Court’s Memorandum Findings of Fact and Opinion filed April 11, 2000, and its Memorandum Opinion filed December 19, 2000. Dr. Ishmael owns both Mid-Del and PC, which operate medical clinics that purchase and use chemotherapy drugs to treat patients with cancer and other serious illnesses. Until 1983, both Mid-Del and PC used the cash method of accounting for tax purposes, reporting the drugs used in patient treatments as supplies and not inventory. That year, Mid-Del switched to the accrual method for its tax purposes. 1 After being audited that year, Mid-Del was required to return to use of the cash method and to pay a tax deficiency of $12,485.

On April 23, 1997, the Commissioner determined that Mid-Del and PC were both required to use the accrual method of accounting in order to clearly reflect their income, and issued tax deficiencies of $140,025 for Mid-Del and $211,979 for PC. 2 Mid-Del and PC separately petitioned the Tax Court, and the cases were consolidated for trial.

The primary arguments at that trial were summarized by the Tax Court as follows:

By regulation, the Secretary has determined that inventories are necessary in every case in which the production, purchase, or sale of merchandise is an income-producing factor in the taxpayer’s business. See sec. 1.471-1, Income Tax Regs. Unless otherwise authorized by the Commissioner, a taxpayer who is required to maintain inventories must use an accrual method of accounting with regard to purchases and sales of inventory....
[The Commissioner] argues that the drugs at issue in this case are merchandise, the purchase and sale of which are income-producing factors in [Mid-Del and PC’s] businesses, and, therefore, [Mid-Del and PC] are required to use the accrual method of accounting to report their taxable income. [Mid-Del and PC] take exception to [the Commissioner’s] characterization of the drugs, countering that the drugs are supplies used in the course of treating patients, with the result that, under their view, the regulations requiring the use of the accrual method are inapplicable.

R. Vol. I, Doc. 30 (T.C. Memo.2000-130) at 18-19 (further citations omitted).

*892 After the cases were tried, but before the opinion was issued, the Tax Court issued an opinion that decided “for the first time whether the furnishing of pharmaceuticals by a medical treatment facility as an integral, indispensable, and inseparable part of the rendering of medical services is the sale of ‘merchandise’ for purposes of section 1.471-1, Income Tax Regs.” Osteopathic Med. Oncology & Hematology, P.C. v. Comm’r, 113 T.C. 376, 380, 1999 WL 1051964 (1999). In that case, the court held that the drugs at issue were not merchandise, and that the taxpayer, which specialized in treating cancer through chemotherapy, properly used the cash method to expense the cost of its drugs and to report income. In the present case, the Tax Court relied heavily on its decision in Osteopathic Med. and found, for the same reasons, that the drugs used by Mid-Del and PC were not merchandise and that, therefore, they were not required to maintain inventories or use the accrual method of accounting. The court found for Mid-Del and PC, and the tax assessments were ultimately abated.

Mid-Del and PC subsequently filed for litigation costs pursuant to 26 U.S.C. § 7430. The Tax Court denied that motion, finding the Commissioner’s position at trial, although unsuccessful, was substantially justified. This appeal followed.

II.

We review the Tax Court’s denial of litigation costs for an abuse of discretion. Barford v. Comm’r, 194 F.3d 782, 786 (7th Cir.1999); see also Pate v. United States, 982 F.2d 457, 459 (10th Cir.1993) (applying same standard to district court applying § 7430). In applying this deferential standard, we are reminded by the Supreme Court “that a request for attorney’s fees should not result in a second major litigation.” Pierce v. Underwood, 487 U.S. 552, 563, 108 S.Ct. 2541, 101 L.Ed.2d 490 (1988) (quotation omitted). Section 7430 states in pertinent part that “[i]n any ... court proceeding which is brought by or against the United States in connection with the determination, collection, or refund of any tax, interest or penalty under [the Internal Revenue Code], the prevailing party may be awarded ... reasonable litigation costs incurred in connection with such court proceeding.” 26 U.S.C. § 7430(a)(2). A prevailing party is one who has substantially prevailed in the amount in controversy or has substantially prevailed with respect to the most significant issue or set of issues presented. 26 U.S.C. § 7430(c)(4)(A). If the United States can establish that its litigating position was substantially justified, the petitioners will not qualify as prevailing parties. Id. § 7430(c)(4)(B). Here, the parties agree that Mid-Del and PC substantially prevailed, and dispute only whether the government’s position was substantially justified.

The term “substantially justified” means “justified to a degree that could satisfy a reasonable person” or having a “reasonable basis both in law and fact.” Pierce, 487 U.S. at 565, 108 S.Ct. 2541 (quotation omitted). In determining whether the position of the United States was substantially justified, “the court must look at all the facts and circumstances as well as relevant legal precedent.” Anthony v. United States, 987 F.2d 670, 674 (10th Cir.1993).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jason Bontrager v. Commissioner
2019 T.C. Memo. 45 (U.S. Tax Court, 2019)
Dalton v. Comm'r
2011 T.C. Memo. 136 (U.S. Tax Court, 2011)
SIERRA CLUB NORTHSTAR CHAPTER v. Kimbell
640 F. Supp. 2d 1082 (D. Minnesota, 2009)
ROWE v. COMMISSIONER
2002 T.C. Memo. 136 (U.S. Tax Court, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
30 F. App'x 889, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mid-del-therapeutic-center-inc-v-commissioner-ca10-2002.